GlassScriptPhysician profile
Julie D Willis
NPI 1609407642
$673.01
in general payments reported to CMS, 2019-2025
11 companies · $30.85 in 2025
The $30.85 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.97 · 2022: $17.72 · 2023: $266 · 2024: $341 · 2025: $30.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $249.98 | 2024 | |
| Gm Pharmaceuticals, INC. | $101.59 | 2023 | Vanacof |
| Genzyme Corporation | $98.26 | 2023 | |
| Alk-Abello, INC | $56.02 | 2023-2024 | Odactra, Grastek, Ragwitek |
| Sanofi Pasteur INC. | $41.68 | 2022-2023 | |
| Pfizer INC. | $38.79 | 2024 | |
| Tolmar, INC. | $26.29 | 2024 | |
| Collegium Pharmaceutical, INC. | $17.19 | 2025 | Jornay Pm |
| Corium, LLC | $16.97 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.66 | 2025 | Relexxii |
| Meridian Bioscience INC. | $12.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.